JUN 30, 2020 6:21 AM PDT

PAR glycohydrolase inhibitors to enhance treatment for gliomas

New hope for glioma patients comes in the form of a novel strategy to target tumors, the results of which are published in Cancer Discovery, a journal of the American Association for Cancer Research. The research was spearheaded by investigators at Massachusetts General Hospital who hope to inform mechanisms that will improve treatment options for the disease. 

While patients with glioma brain tumors can receive surgery, radiation, and chemotherapy, these treatment options do not always offer a cure to the disease. However, past work led by Mass General's Daniel Cahill, MD, Ph.D., Hiroaki Wakimoto, MD, Ph.D., and Julie Miller, MD, Ph.D., demonstrated how mutations in the isocitrate dehydrogenase (IDH) genes have a metabolic Achilles heel. What they found is that mutant IDH genes are particularly susceptible to treatments that lower levels of NAD+, an important metabolic molecule. 

So the researchers combined this knowledge with another key piece of information: chemotherapy activates an enzyme that stimulates NAD+ molecules to unite to produce poly(ADP-ribose), or PAR, which is a key DNA damage signal. And it only does this in IDH mutant glioma cells, not healthy cells. 

Knowing this, the researchers figured this provided the perfect opportunity to target IDH mutant glioma cells by maintaining high PAR levels and low NAD+ levels through chemotherapy.

Gliomas account for about 25% of childhood cancers. Photo: Pixabay

"We found that maximum effectiveness was achieved by combining two agents: temozolomide, the chemotherapy most commonly used to treat patients with IDH mutant gliomas, with a drug that blocks PAR breakdown, known as a PAR glycohydrolase inhibitor," said Dr. Cahill, 

Dr. Wakimoto continues, explaining: "We showed, for the first time, that PAR glycohydrolase inhibitors can be used to enhance the effectiveness of chemotherapy in tumors with metabolic weaknesses in the NAD+ pathway.”

Dr. Miller concludes that their findings have real-life implications for glioma patients. "The long-term significance is that, based on our findings, they could be tested in individuals with IDH mutant gliomas, with a goal of hopefully improving outcomes in these patients," she said.

Sources: Cancer Discovery, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 23, 2020
Cancer
Platelets May Protect Cancer Against PD-1 Therapies
NOV 23, 2020
Platelets May Protect Cancer Against PD-1 Therapies
One of cancer’s greatest tools is its ability to manipulate the immune system. Many cancer therapies have arisen t ...
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
DEC 21, 2020
Cancer
Cancer survivors have a higher risk of developing subsequent primary cancers
DEC 21, 2020
Cancer survivors have a higher risk of developing subsequent primary cancers
New research published in JAMA has found that cancer survivors have a higher risk of developing subsequent primary cance ...
DEC 24, 2020
Cancer
Seven DNA fingerprints determine genetic predisposition for cancer
DEC 24, 2020
Seven DNA fingerprints determine genetic predisposition for cancer
New research published in Science Advances is attempting to change the way that we think about cancer. The research ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 12, 2021
Cancer
The frightening association between oral sex and HPV-related cancers
JAN 12, 2021
The frightening association between oral sex and HPV-related cancers
New research published recently in the online edition of CANCER, a peer-reviewed journal of the American Cancer Soc ...
Loading Comments...